FRISON, LUCA
 Distribuzione geografica
Continente #
EU - Europa 130
NA - Nord America 121
AS - Asia 53
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 307
Nazione #
US - Stati Uniti d'America 121
GB - Regno Unito 56
CN - Cina 51
SE - Svezia 17
IE - Irlanda 14
IT - Italia 11
FR - Francia 9
DE - Germania 7
FI - Finlandia 7
PL - Polonia 4
BE - Belgio 3
IN - India 2
AU - Australia 1
DZ - Algeria 1
EU - Europa 1
NL - Olanda 1
UA - Ucraina 1
Totale 307
Città #
Southend 52
Chandler 32
Woodbridge 30
Beijing 15
Dublin 14
Ann Arbor 12
Jinan 9
Shenyang 7
Verona 5
Guangzhou 4
Hebei 4
Jacksonville 4
Lawrence 4
Princeton 4
Wilmington 4
Brussels 3
Changsha 3
Polska 3
Ashburn 2
Düsseldorf 2
Nanjing 2
Washington 2
Bologna 1
Canberra 1
Chester 1
Dobczyce 1
Fremont 1
Fuzhou 1
Haikou 1
Hanover 1
Hefei 1
Houston 1
Jiaxing 1
Jinhua 1
Nanchang 1
New Delhi 1
Oklahoma City 1
Salsomaggiore Terme 1
San Francisco 1
Thornton Heath 1
Totale 235
Nome #
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 90
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 79
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 77
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 69
Totale 315
Categoria #
all - tutte 822
article - articoli 302
book - libri 0
conference - conferenze 520
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201918 0 0 0 1 1 5 5 5 0 0 0 1
2019/202045 4 4 0 0 4 7 0 6 4 3 5 8
2020/202123 1 5 1 4 5 2 0 0 0 0 3 2
2021/202231 5 9 0 3 3 0 0 2 0 0 1 8
2022/202386 4 11 6 15 7 22 2 4 11 3 1 0
2023/20249 1 5 3 0 0 0 0 0 0 0 0 0
Totale 315